ZA200304799B - Pharmaceutical preparation with retarded active ingredient release, method for manufacture thereof and use thereof. - Google Patents

Pharmaceutical preparation with retarded active ingredient release, method for manufacture thereof and use thereof.

Info

Publication number
ZA200304799B
ZA200304799B ZA200304799A ZA200304799A ZA200304799B ZA 200304799 B ZA200304799 B ZA 200304799B ZA 200304799 A ZA200304799 A ZA 200304799A ZA 200304799 A ZA200304799 A ZA 200304799A ZA 200304799 B ZA200304799 B ZA 200304799B
Authority
ZA
South Africa
Prior art keywords
manufacture
active ingredient
pharmaceutical preparation
ingredient release
retarded active
Prior art date
Application number
ZA200304799A
Other languages
English (en)
Inventor
Klaus-Dieter Kuehn
Matthhias Schnabelrauch
Sebastian Vogt
Original Assignee
Heraeus Kulzer Gmbh & Co Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Heraeus Kulzer Gmbh & Co Kg filed Critical Heraeus Kulzer Gmbh & Co Kg
Publication of ZA200304799B publication Critical patent/ZA200304799B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA200304799A 2002-06-21 2003-06-20 Pharmaceutical preparation with retarded active ingredient release, method for manufacture thereof and use thereof. ZA200304799B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10227914A DE10227914A1 (de) 2002-06-21 2002-06-21 Pharmazeutische Zubereitung mit retardierender Wirkstofffreisetzung, Verfahren zu ihrer Herstellung und Verwendung

Publications (1)

Publication Number Publication Date
ZA200304799B true ZA200304799B (en) 2004-04-29

Family

ID=29716599

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200304799A ZA200304799B (en) 2002-06-21 2003-06-20 Pharmaceutical preparation with retarded active ingredient release, method for manufacture thereof and use thereof.

Country Status (13)

Country Link
US (1) US7264825B2 (pt)
EP (1) EP1374854B1 (pt)
JP (1) JP2004026827A (pt)
CN (1) CN1283318C (pt)
AT (1) ATE333865T1 (pt)
AU (1) AU2003204859B2 (pt)
BR (1) BR0301708A (pt)
CA (1) CA2432006C (pt)
DE (2) DE10227914A1 (pt)
DK (1) DK1374854T3 (pt)
ES (1) ES2264505T3 (pt)
PT (1) PT1374854E (pt)
ZA (1) ZA200304799B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7144857B2 (en) * 2004-01-15 2006-12-05 Murali Dharan Vancomycin haemostatic paste composition
WO2006015545A1 (fr) * 2004-08-11 2006-02-16 Shenzhen Tys R & D Co., Ltd. Capsule de gelatine de moxifloxacin et procede pour sa preparation
DE102004060666B3 (de) 2004-12-15 2006-03-30 Heraeus Kulzer Gmbh Antibiotikum/Antibiotika enthaltendes Knochenersatzmaterial mit retardierender Wirkstofffreisetzung
GB0618963D0 (en) * 2006-09-26 2006-11-08 Ucl Business Plc Formulations and composites with reactive fillers
US20080082038A1 (en) * 2006-09-28 2008-04-03 Vance Products Incorporated, D/B/A/ Cook Urological Incorporated Medical Device including a Bioactive in a Non-ionic and an Ionic Form and Methods of Preparation Thereof
US20080108824A1 (en) * 2006-09-28 2008-05-08 Med Institute, Inc Medical Devices Incorporating a Bioactive and Methods of Preparing Such Devices
EP2068958B1 (en) * 2006-09-28 2016-10-19 Cook Medical Technologies LLC Medical device including an anesthetic and method of preparation thereof
DE102007063613B4 (de) * 2007-04-24 2010-01-07 Heraeus Kulzer Gmbh Verwendung eines Spacer-Polymethylmethacrylat-Knochenzement
DE102007029098B4 (de) * 2007-04-24 2010-12-09 Heraeus Kulzer Gmbh Spacer-Polymethylmethacrylat-Knochenzement und seine Verwendung
CN103977456A (zh) * 2014-06-05 2014-08-13 赵全明 一种载万古霉素/羟基磷灰石人工关节假体的制备工艺
US9492374B2 (en) 2015-03-25 2016-11-15 Jose Rafael Salinas Andrade Composition and method for treatment of ulcers
CN104910259A (zh) * 2015-06-02 2015-09-16 苏州纳微科技有限公司 一种替考拉宁的层析纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4283799A (en) * 1979-09-10 1981-08-18 Massachusetts Institute Of Technology Pre-coated body implant
DE3245956A1 (de) * 1982-12-11 1984-06-14 Beiersdorf Ag, 2000 Hamburg Chirurgisches material
DE4304716A1 (de) * 1993-02-16 1994-08-18 Melzer Wolfgang Lokal applizierbares Arzneimittel mit verzögerter Freisetzung
DE4433201A1 (de) * 1994-09-17 1996-03-21 Merck Patent Gmbh Verfahren zur Herstellung von wirkstoffhaltigen Knochenzementen
US6375982B1 (en) * 2000-07-05 2002-04-23 Capricorn Pharma, Inc. Rapid-melt semi-solid compositions, methods of making same and method of using same
DE50006026D1 (de) 2000-08-01 2004-05-13 Coripharm Medizinprodukte Gmbh Wirkstoffhaltiges implantat-baustein-system und verfahren zu dessen herstellung

Also Published As

Publication number Publication date
DK1374854T3 (da) 2006-09-11
EP1374854B1 (de) 2006-07-26
AU2003204859B2 (en) 2005-08-25
ES2264505T3 (es) 2007-01-01
CN1480218A (zh) 2004-03-10
CA2432006C (en) 2010-03-16
CN1283318C (zh) 2006-11-08
CA2432006A1 (en) 2003-12-21
AU2003204859A1 (en) 2004-01-15
DE10227914A1 (de) 2004-01-15
US20040052841A1 (en) 2004-03-18
BR0301708A (pt) 2004-08-24
US7264825B2 (en) 2007-09-04
EP1374854A1 (de) 2004-01-02
ATE333865T1 (de) 2006-08-15
JP2004026827A (ja) 2004-01-29
PT1374854E (pt) 2006-11-30
DE50304336D1 (de) 2006-09-07

Similar Documents

Publication Publication Date Title
ZA200304799B (en) Pharmaceutical preparation with retarded active ingredient release, method for manufacture thereof and use thereof.
IL304804A (en) Attach a bioactive substance, a method for its preparation and use
WO2010017821A8 (en) Coated tablets with a remaining degradation surface over the time
CA2431984C (en) Antibiotic coating for porous bodies and method for its production as well as its use
WO2007067520A3 (en) Lipid-based compositions of antiinfectives for treating pulmonary infections
WO2007054976A3 (en) Lipid based controlled release pharmaceutical composition
WO2005027843A3 (en) Chronotherapeutic dosage forms
EP3604304A4 (en) PYRROLO-PYRIDINE DERIVATIVE COMPOUND, METHOD OF MANUFACTURING AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE PREVENTION OR TREATMENT OF PROTEIN KINASE-RELATED DISEASES
EP4159203A4 (en) SUSTAINED-RELEASE ORAL COMPOSITION FOR AN INSOLUBLE DRUG, AND PREPARATION METHOD THEREFOR
WO2006030297B1 (en) Taste masked granules comprising clarithromycin, hydrocolloids and a coating
MX2009008197A (es) Forma de dosificacion de liberacion extendida.
NO20075715L (no) Depotsammensetning omfattende cefalosporin for behandling av en bakterieinfeksjon
AU2012264783B2 (en) Method for producing an implant coating, and corresponding implant
AU2004200955B2 (en) Porous Body with Antibiotic Coating, Process for Production, and Use
EP1820496A3 (de) Implantatmaterial
EP4215529A4 (en) HETEROARYL DERIVATIVE, METHOD FOR PRODUCING SAME AND PHARMACEUTICAL COMPOSITION CONTAINING IT AS ACTIVE INGREDIENT
EP4140989A4 (en) NOVEL 2-ARYLTHIAZOLE DERIVATIVE OR SALT THEREOF, PROCESS THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF
WO2004037226A3 (en) Pharmaceutical compositions containing venlafaxine
EP4296266A4 (en) S-CONFIGURATION WITH AMINOBENZAMIDPYRIDAZINONE COMPOUND, PROCESS FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION AND USE THEREOF
ES2181593A1 (es) Metodo para la obtencion de implantes bioactivos utiles como sistemas de liberacion controlada de antibioticos.
EP4105217A4 (en) 3-((8-(1H-PYRAZOL-4-YL)AMINO)IMIDAZO[1,2-A PYRIDINE-3-YL)ETHINYL)-N-PHENYLBENZAMIDE DERIVATIVE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION USING IT AS AN ACTIVE INGREDIENT
EP4177255A4 (en) OXADIAZOLE COMPOUND, METHOD FOR PREPARING SAME, PHARMACEUTICAL COMPOSITION AND ASSOCIATED USE
EP4108236A4 (en) PHARMACEUTICAL OLAPARIB COMPOSITION, MANUFACTURE THEREOF, MANUFACTURING METHOD THEREOF AND USE THEREOF
WO2005123137A3 (en) Lyophilized pharmaceutical composition comprising moxifloxacin hydrochloride
WO2010089772A3 (en) Chronotherapeutic pharmaceutical composition